BioSpace News Archive

Business

WITH RECORD CUSTOMER GROWTH, GENXYS SUPPORTS RIGHT DRUG DOSE NOW ACT TO REDUCE ADVERSE DRUG REACTIONS THROUGH PRECISION MEDICINE

GenXys Health Care Systems, Inc., the global leader in precision prescribing software with embedded pharmacogenetic data, added a record five pharmacogenetic companies as customers in the first quarter of 2022.

April 21, 2022
·
3 min read
Biotech Bay

Curebase selected to launch a clinical investigation of a digital therapeutic for IPF

Curebase, a company committed to democratizing access to clinical studies, today announced the initiation of the pilot phase of COMPANION, the first clinical investigation of a new digital therapeutic (DTx) for patients with IPF, a rare lung disease.

April 21, 2022
·
5 min read
Business

Revolution Medicines to Report Financial Results for First Quarter 2022 After Market Close on May 9, 2022

Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers, today announced that it will report financial results for the first quarter 2022 on Monday, May 9, 2022, after market close.

April 21, 2022
·
1 min read
Business

Puma Biotechnology to Host Conference Call to Discuss First Quarter 2022 Financial Results

Puma Biotechnology, Inc., a biopharmaceutical company, will host a conference call at 1:30 p.m. PDT/4:30 p.m. EDT on Thursday, May 5, 2022, following the release of its first quarter 2022 financial results.

April 21, 2022
·
2 min read
Biotech Bay

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Apr 21, 2022

Geron Corporation reported that it has granted non-statutory stock options to purchase an aggregate of 505,800 shares of Geron common stock as inducements to newly hired employees in connection with commencement of employment with the Company.

April 21, 2022
·
1 min read